UK regulator set to approve COVID-19 vaccine next week - FT

Britain has ordered 40 million doses of the vaccine, which has been found to be 95% effective in preventing the spread of a virus that has killed more than 1.4 million people worldwide and crippled the global economy. The government asked the regulator on Friday to assess AstraZeneca Plc's COVID-19 vaccine for a possible rollout.

Reuters | Updated: 28-11-2020 21:37 IST | Created: 28-11-2020 21:30 IST
UK regulator set to approve COVID-19 vaccine next week - FT
Britain has ordered 40 million doses of the vaccine, which has been found to be 95% effective in preventing the spread of a virus that has killed more than 1.4 million people worldwide and crippled the global economy. Image Credit: ANI

Britain is set to approve the COVID-19 vaccine developed by BioNTech SE and Pfizer Inc next week and deliveries would begin within hours of the authorisation, the Financial Times reported on Saturday.

The first immunisations using the BioNTech and Pfizer vaccine could take place from Dec. 7, the FT said, citing unnamed sources. https://on.ft.com/3o6JrSG Earlier in the day, British Prime Minister Boris Johnson named Nadhim Zahawi, currently a junior business minister, as the minister responsible for the deployment of COVID-19 vaccines.

Britain said on Nov. 20 it had formally asked its medical regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA), to assess the Pfizer-BioNTech COVID-19 vaccine for its suitability, the first step in making it available outside the United States. Britain has ordered 40 million doses of the vaccine, which has been found to be 95% effective in preventing the spread of a virus that has killed more than 1.4 million people worldwide and crippled the global economy.

The government asked the regulator on Friday to assess AstraZeneca Plc's COVID-19 vaccine for a possible rollout. It has secured 100 million doses of the vaccine developed by AstraZeneca and Oxford University and has targeted a rollout to begin before Christmas.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

Africa secures 400 million more COVID-19 vaccine doses

The African Union AU has secured another 400 million doses of the AstraZeneca COVID-19 vaccine, a regional health leader said on Thursday, in a push to immunize 60 of the continents population over three years. As richer nations race ahead ...

Russia flies planeload of Sputnik V vaccine to Argentina and Bolivia

Russia dispatched 240,000 doses of its Sputnik V coronavirus vaccine on Thursday, with most heading to Argentina and the rest bound for Bolivia, Argentine health and airline officials said.Bolivia, which an airline official said would take ...

WHO Europe: Vaccine production delays are a real issue

National tensions are erupting over slow coronavirus vaccine rollouts but production delay issues are real and world leaders must realize that no one is safe until everyone is safe, the European chief for the World Health Organization said ...

AstraZeneca prepared to publish EU vaccine contract - FAZ

Pharmaceuticals company AstraZeneca is prepared to publish the delivery contract it has with the European Union and aims on Friday to make proposals to the European Commission on which sensitive parts to black out, the Frankfurter Allgemein...

Give Feedback